Pharmabiz

CureMeAbroad raises $1.1 million in pre-seed round led by SteerX Ventures with existing investor AIRA

CureMeAbroad raises $1.1 million in pre-seed round led by SteerX Ventures with existing investor AIRA: Our Bureau, Bengaluru ...
Pharmabiz

US FDA accepts and grants priority review status to BridgeBio’s NDA of oral infigratinib for children with achondroplasia

US FDA accepts and grants priority review status to BridgeBio’s NDA of oral infigratinib for children with achondroplasia: Palo Alto, California Wednesday, October 7, 2026, 17:0 ...
Pharmabiz

ZEISS India inks a multi-year strategic pacts with Dr Agarwal’s Eye Hospital and Narayana Nethralaya

ZEISS India inks a multi-year strategic pacts with Dr Agarwal’s Eye Hospital and Narayana Nethralaya: Our Bureau, Bengaluru Wednesday, October 7, 2026, 16:30 Hrs [IST] ZEISS Ind ...
Pharmabiz

Vitalant launches cell-based analytics lab to support allogeneic therapy developers

Vitalant launches cell-based analytics lab to support allogeneic therapy developers: Phoenix Wednesday, October 7, 2026, 18:00 Hrs [IST] Vitalant, one of the nation’s largest no ...
Pharmabiz

Cerenome introduces CNSide CSF Molecular Profile tests

CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Cerenome), announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to ...
Pharmabiz

Cognizant unveils Cognizant Activate to bring Enterprise AI transformation for emerging enterprises including pharma

Cognizant unveils Cognizant Activate to bring Enterprise AI transformation for emerging enterprises including pharma: Our Bureau, Bengaluru Wednesday, October 7, 2026, 16:15 Hrs [ ...
Pharmabiz

ArriVent’s FURVENT phase 3 trial of firmonertinib in first-line EGFR Exon 20 insertion mutant NSCLC fails to meet primary endpoint

ArriVent’s FURVENT phase 3 trial of firmonertinib in first-line EGFR Exon 20 insertion mutant NSCLC fails to meet primary endpoint: Newtown Square, Pennsylvania Wednesday, Octob ...
Pharmabiz

Eris Lifesciences appoints Chirag Mehta as executive director

Eris Lifesciences Limited announced the appointment of Chirag Mehta as executive director. He will be based at the company’s Mumbai office and will report to the CMD. In his non-statutory executive ...
Pharmabiz

GE HealthCare to buy US-based CMO for PET radiopharmaceuticals, SOFIE Biosciences from Trilantic North America for $945 million

GE HealthCare announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million ...
Pharmabiz

Fischer Medical Ventures announces leadership appointments across Group cos

Fischer Medical Ventures announces leadership appointments across Group cos: Our Bureau, Mumbai Wednesday, October 7, 2026, 14:20 Hrs [IST] Fischer Medical Ventures Limited named ...
Pharmabiz

Granules India files Paragraph IV certification on Ruxolitinib ER tablets

Granules India files Paragraph IV certification on Ruxolitinib ER tablets: Our Bureau, Mumbai Wednesday, October 7, 2026, 17:15 Hrs [IST] Granules India Limited announced that it ...
Pharmabiz

Sunfox raises $7 million to scale its heart attack diagnostics platform Spandan

Sunfox raises $7 million to scale its heart attack diagnostics platform Spandan: Our Bureau, Bengaluru Wednesday, October 7, 2026, 13:30 Hrs [IST] Sunfox Technologies, the Dehradu ...